Revolution Medicines Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 16.72 M | $1.33 B | 6.75% | 8.84% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 14.58 M | $1.16 B | -0.29% | 7.71% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 12.30 M | $980.04 M | 8.34% | 6.50% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 9.46 M | $753.12 M | 0.00% | 5.00% |
| BLACKROCK, INC. | 02/12/2026 | 8.93 M | $711.01 M | 7.19% | 4.72% |
| FMR LLC | 02/17/2026 | 8.59 M | $684.03 M | -8.65% | 4.54% |
| NEXTECH INVEST, LTD. | 02/17/2026 | 7.60 M | $605.43 M | 0.00% | 4.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 6.99 M | $556.57 M | -28.80% | 3.69% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 6.64 M | $529.23 M | 6.77% | 3.51% |
| BELLEVUE GROUP AG | 02/17/2026 | 5.01 M | $398.71 M | -10.19% | 2.65% |
| STATE STREET CORP | 02/13/2026 | 4.11 M | $327.30 M | -21.80% | 2.17% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.40 M | $271.19 M | -12.11% | 1.80% |
| BVF INC/IL | 02/17/2026 | 3.36 M | $267.37 M | -15.55% | 1.77% |
| ALPHABET INC. | 02/13/2026 | 3.35 M | $266.44 M | -19.07% | 1.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.16 M | $251.91 M | 0.52% | 1.67% |
| UBS GROUP AG | 01/29/2026 | 3.09 M | $245.95 M | 183.57% | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 2.89 M | $230.56 M | -20.70% | 1.53% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2026 | 2.85 M | $226.61 M | 13.17% | 1.50% |
| GENERAL ATLANTIC, L.P. | 02/17/2026 | 2.81 M | $224.05 M | 13.68% | 1.49% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 2.58 M | $205.28 M | -2.64% | 1.36% |
| WOODLINE PARTNERS LP | 02/17/2026 | 2.50 M | $199.20 M | -14.23% | 1.32% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.49 M | $198.45 M | 237.60% | 1.32% |
| NORGES BANK | 02/10/2026 | 2.46 M | $195.57 M | 100.00% | 1.30% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 2.21 M | $175.67 M | 197.08% | 1.17% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 2.20 M | $175.26 M | -53.99% | 1.16% |
| LUNATE CAPITAL LTD | 01/23/2026 | 2.20 M | $174.93 M | 0.00% | 1.16% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 2.17 M | $172.84 M | 100.00% | 1.15% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 2.06 M | $163.83 M | 67.94% | 1.09% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 2.01 M | $160.40 M | 321.20% | 1.06% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 2.00 M | $159.30 M | 14.29% | 1.06% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 1.91 M | $151.97 M | -44.49% | 1.01% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.68 M | $134.11 M | 2.96% | 0.89% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.61 M | $128.53 M | 98.67% | 0.85% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 1.34 M | $106.35 M | 0.00% | 0.71% |
| SIREN, L.L.C. | 02/13/2026 | 1.34 M | $106.34 M | 27.92% | 0.71% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.30 M | $103.73 M | 10.36% | 0.69% |
| CALIGAN PARTNERS LP | 02/17/2026 | 1.28 M | $102.26 M | 20.64% | 0.68% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 1.20 M | $95.58 M | 200.00% | 0.63% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.16 M | $92.53 M | -19.38% | 0.61% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 1.14 M | $90.90 M | 8,678.42% | 0.60% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.14 M | $90.65 M | -13.31% | 0.60% |
| JANE STREET GROUP, LLC | 02/12/2026 | 1.09 M | $86.85 M | 82.51% | 0.58% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.06 M | $84.44 M | 11.42% | 0.56% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.03 M | $82.12 M | 18.68% | 0.54% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 1.00 M | $79.65 M | 0.00% | 0.53% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 945.59 K | $75.32 M | 1.88% | 0.50% |
| AH CAPITAL MANAGEMENT, L.L.C. | 02/17/2026 | 921.10 K | $73.37 M | -66.49% | 0.49% |
| 02/05/2026 | 900.39 K | $71.72 M | 100.00% | 0.48% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 887.10 K | $70.66 M | 17.78% | 0.47% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 879.85 K | $70.08 M | 16.71% | 0.47% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Revolution Medicines Inc institutional Ownership - FAQ's
During the previous two years, 489 institutional investors and hedge funds held shares of Revolution Medicines Inc. The most heavily invested institutionals were:
UBS Group AG: 4.39 M
Bank of New York Mellon Corp: 635,366
Candriam S.C.A.: 580,677
Pictet Asset Management Holding SA: 557,560
Lunate Capital Ltd: 549,050
Mass General Brigham, Inc: 344,091
105.34% of Revolution Medicines Inc stock is owned by institutional investors.
Institutional investors have bought a total of 236.51 M shares in the last 24 months. This purchase volume represents approximately $23.60 B in transactions.